Patent details

EP3200783 Title: ERYTHROMELALGIA TREATMENT

Basic Information

Publication number:
EP3200783
PCT Application Number:
GB2015052885
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157906223
PCT Publication Number:
WO2016051194
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ERYTHROMELALGIA TREATMENT
French Title of Invention:
TRAITEMENT DE L'ÉRYTHROMÉLALGIE
German Title of Invention:
BEHANDLUNG VON ERYTHROMELALGIE
SPC Number:

Dates

Filing date:
02/10/2015
Grant date:
31/07/2019
EP Publication Date:
09/08/2017
PCT Publication Date:
07/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/07/2019
EP B1 Publication Date:
31/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/10/2023
Expiration date:
02/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/07/2019
 
 

Name:
Convergence Pharmaceuticals Limited
Address:
90 High Holborn, London WC1V 6XX, United Kingdom (GB)

Agent

Name:
STOLMÁR & PARTNER
From:
04/11/2019
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

Name:
MORISSET, Valerie
Address:
United Kingdom (GB)

Priority

Priority Number:
201417497
Priority Date:
03/10/2014
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/401; A61P 25/02; A61P 29/00; C12Q 1/68; C12Q 1/6883;

Publication

European Patent Bulletin

Issue number:
201931
Publication date:
31/07/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/09/2022
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
04/11/2019 Power Of Attorney 1
05/11/2019 Outgoing Correspondence 1